New data from Ramp reveals a notable slowdown in artificial intelligence (AI) spending just as Anthropic, a leading AI startup, approaches its initial public offering (IPO). The trend indicates a cautionary stance among businesses and investors amid market uncertainties and evolving AI industry dynamics. Despite the excitement surrounding Anthropic’s upcoming IPO, the data suggests companies are tightening budgets and delaying AI investments. This slowdown comes at a critical time when AI development and deployment were expected to accelerate rapidly. Industry experts believe the stalling in AI spending could impact innovation and growth within the sector. However, Anthropic’s IPO remains a significant milestone, potentially influencing future AI market trends and investor confidence. Monitoring these developments will be essential for understanding the broader financial landscape of AI technologies.
TechCrunchNew data shows nipocalimab significantly improves dry mouth symptoms in Sjögren’s syndrome patients
November 8, 2026
New data from Johnson & Johnson’s Phase 2 clinical study reveals that nipocalimab demonstrates promising results in improving dry mouth symptoms associated with Sjögren’s syndrome.